Health - Google News: Isis trading halts as FDA reviews key drug's risks - Businessweek

Health - Google News Google News

Isis trading halts as FDA reviews key drug's risks - Businessweek Oct 18th 2012, 17:03 Isis trading halts as FDA reviews key drug's risks Businessweek Drug developer Isis Pharmaceuticals Inc. said Thursday that Nasdaq has halted trading of its common stock as advisers to U.S. regulators hold a crucial meeting to review safety concerns and patient test results on what investors had hoped would be the ... Benzinga Mid-Morning Market UpdateNASDAQ ISIS Pharmaceuticals Trader Expects an Extended DeclineSchaeffers Research (blog) all 23 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: